Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Scientific Industries (SCND) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Scientific Industries (SCND) over the last 16 years, with Q3 2025 value amounting to $863600.0.

  • Scientific Industries' Cash from Investing Activities rose 51.21% to $863600.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 26886.91%. This contributed to the annual value of $2.9 million for FY2024, which is 48987.89% up from last year.
  • According to the latest figures from Q3 2025, Scientific Industries' Cash from Investing Activities is $863600.0, which was up 51.21% from $376700.0 recorded in Q2 2025.
  • In the past 5 years, Scientific Industries' Cash from Investing Activities registered a high of $1.9 million during Q2 2023, and its lowest value of -$6.1 million during Q2 2021.
  • Its 5-year average for Cash from Investing Activities is -$339670.6, with a median of $454100.0 in 2021.
  • Over the last 5 years, Scientific Industries' Cash from Investing Activities had its largest YoY gain of 314765.1% in 2021, and its largest YoY loss of 3428707.87% in 2021.
  • Scientific Industries' Cash from Investing Activities (Quarter) stood at -$63700.0 in 2021, then skyrocketed by 1460.44% to $866600.0 in 2022, then tumbled by 577.22% to -$4.1 million in 2023, then skyrocketed by 110.55% to $436100.0 in 2024, then soared by 98.03% to $863600.0 in 2025.
  • Its Cash from Investing Activities was $863600.0 in Q3 2025, compared to $376700.0 in Q2 2025 and $1.2 million in Q1 2025.